ZYDUS LIFESCIENCES LIMITED Share Price & Technical Analysis
ZYDUSLIFE · ₹1,127 (+1.05%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹1,127
+1.05%
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Consumer Products, and Medical Technologies. The company offers active pharmaceutical ingredients, human and finished dosage formulations, generics, br…
Price chart
Seasonality
Aug has 2 positive and 2 negative years (last 5 years shown)
24% return in 2026, 23% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -4% | 5% | -3% | 0% | 21% | 3% | 1% | – | – | – | – | – | 24% |
| 25 | 0% | -10% | 1% | 0% | 5% | 6% | -3% | 1% | -1% | -1% | -3% | -3% | -7% |
| 24 | 11% | 23% | 6% | -7% | 4% | 3% | 14% | -10% | -5% | -7% | -4% | 1% | 28% |
| 23 | 3% | 7% | 5% | 4% | -3% | 16% | 8% | -1% | -2% | -7% | 11% | 7% | 48% |
| 22 | -16% | -12% | -2% | 0% | 8% | -4% | -3% | 9% | 2% | 11% | -6% | 2% | -11% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Consumer Products, and Medical Technologies. The company offers active pharmaceutical ingredients, human and finished dosage formulations, generics, branded generics, specialty formulations, biosimilars, vaccines, novel therapeutics, medical devices and technologies, consumer wellness, veterinary, and animal health products. It also provides biological products in the areas of oncology, autoimmune disorders, nephrology, inflammation, rheumatology, hepatology, and infectious diseases; and designs and executes clinical trials across new chemical entities (NCEs), biologics, vaccines, and specialty generics. In addition, the company operates seasonal, skin and healthcare, and food and nutrition products under the Glucon D, Complan, Sugar Free, Nycil, Everyuth, Nutralite, and RiteBite Max Protein brands. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹1.12T
P/E ratio
22.5
52W high
₹1,182
52W low
₹835.5
Volume
7,21,017
Beta
0.40
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹3,274
Frequently asked questions
- What is ZYDUS LIFESCIENCES LIMITED share price today?
- ZYDUS LIFESCIENCES LIMITED (ZYDUSLIFE) last traded around ₹1,127 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ZYDUSLIFE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ZYDUSLIFE. Download the app for real-time alerts.
- How can I analyze ZYDUS LIFESCIENCES LIMITED stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.